Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Events
  • Tools
    • Members
    • Groups
    • Add/Edit Event
    • My Bookings
      • Manage Bookings
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
  • COVID-19

Meloxicam

Baudax Bio, Inc.
Business

Baudax Bio Awarded Group Purchasing Agreement with Premier Inc. for ANJESO

August 26, 2020August 26, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has been awarded a Group Purchasing Agreement with Premier …

Read More

Baudax Bio, Inc.
Products and Services

Malvern-based Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from Centers for Medicare and Medicaid Services

August 7, 2020August 6, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that the Centers for Medicare and Medicaid Services (CMS) established a …

Read More
Baudax Bio, Inc.
Products and Services / Research

Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data

August 1, 2020August 1, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced a virtual poster presentation highlighting new Phase IIIb ANJESO® (meloxicam) injection …

Read More

Baudax Bio, Inc.
Health / Medical / Products and Services

Baudax Bio Secures Pharmacy Supplier Agreement with Vizient Inc. for ANJESO®

July 21, 2020July 21, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has entered into a Pharmacy Supplier Agreement with Vizient, …

Read More
Baudax Bio, Inc.
Products and Services / Research

Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at Digestive Disease Week 2020

May 7, 2020May 6, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced a virtual poster presentation highlighting ANJESO™ (meloxicam) injection data at Digestive …

Read More

Baudax Bio, Inc.
Research

Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at the 45th Annual Regional Anesthesiology and Acute Pain Medicine Meeting

April 25, 2020April 25, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced two virtual poster presentations highlighting new ANJESO™ (meloxicam) injection data at …

Read More
Baudax Bio Announces U.S. Availability of ANJESO™ (meloxicam) Injection for the Management of Moderate to Severe Pain
Medical Products / Products and Services

Baudax Bio Announces U.S. Availability of ANJESO™ (meloxicam) Injection for the Management of Moderate to Severe Pain

April 8, 2020April 8, 2020 - by MyChesCo

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential …

Read More

Fiscal Results
Finance

Recro Pharma Reports Record Results and Raising Guidance; Announces Plan to Spin Acute Care

August 10, 2019August 8, 2019 - by MyChesCo

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a pharmaceutical company with a high-performing, revenue-generating contract development and manufacturing (CDMO) segment and an Acute Care segment, reported financial results for the three and …

Read More
Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development
Products and Services / Publications

Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development

February 26, 2019February 25, 2019 - by MyChesCo

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a revenue-generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, announced the publication of clinical data from its Phase III …

Read More
NASDAQ
Finance

Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018

February 20, 2019February 20, 2019 - by MyChesCo

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a revenue-generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, reported financial results for the fourth quarter and year …

Read More

Most Read

  • Bill Gates-Funded Solar Dimming Project Risks the Lives of Millions and Must be Stopped
  • Pennsylvania Experiences Record Firearm Background Checks in Fourth Quarter 2020
  • Department of Health Highlights December 2020 Nursing Home Inspection, Sanction Information Amidst COVID-19 Pandemic
  • Interagency Health Reform Recommendations Provide Path to Healthier Pennsylvania
  • Last-Minute Changes To Tax Laws Included in IRS Forms and Instructions
  • Unemployment Payment Boost To Begin In Pennsylvania

Subscribe for Updates

Chester County Events

  • National Irish Coffee Day at The Watermark at Bellingham Drive-By
    • 01/21/2021
  • A Real-Life Scavenger Hunt for Grown-Ups On King Street,Malvern!
    • 01/21/2021
      Malvern
  • Intro to Practical Defensive Pistol (Indoor)
    • 01/27/2021
      Elverson
  • Pistol Level 1
    • 01/31/2021
      Malvern
  • Women Willpower Topic: High Value Projects | Host: Lisa Morris
    • 02/09/2021
      West Chester
  • all events

Follow Us

  • Facebook
  • Twitter
  • LinkedIn

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy

Recent Articles

  • Interagency Health Reform Recommendations Provide Path to Healthier Pennsylvania
  • Department of Health Highlights December 2020 Nursing Home Inspection, Sanction Information Amidst COVID-19 Pandemic
  • Secretary of Health Announces Week-Seven of Regional Testing Extension Across the Commonwealth
  • Investcorp Invests in Unilog to Accelerate Growth
Copyright © 2021 MyChesCo.